PIDD mediates and stabilizes the interaction between RAIDD and Caspase-2 for the PIDDosome assembly
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The PIDDosome, which is an oligomeric signaling complex composed of PIDD, RAIDD and caspase-2, can induce proximity-based dimerization and activation of caspase-2. In the PIDDosome assembly, the adaptor protein RAIDD interacts with PIDD and caspase-2 via CARD:CARD and DD:DD, respectively. To analyze the PIDDosome assembly,we purified all of the DD superfamily members and performed biochemical analyses. The results revealed that caspase-2CARD is an insoluble protein that can be solubilized by its binding partner, RAIDD CARD, but not by full-length RAIDD;this indicates that full-length RAIDD in closed states cannot interact with caspase-2 CARD. Moreover, we found that caspase-2 CARD can be solubilized and interact with full-length RAIDD in the presence of PIDD DD, indicating that PIDD DD initially binds to RAIDD, after which caspase-2 can be recruited to RAIDD via a CARD:CARD interaction. Our study will be useful in determining the order of assembly of the PIDDosome. [BMB Reports 2013; 46(9): 471-476]
Abstract
The PIDDosome, which is an oligomeric signaling complex composed of PIDD, RAIDD and caspase-2, can induce proximity-based dimerization and activation of caspase-2. In the PIDDosome assembly, the adaptor protein RAIDD interacts with PIDD and caspase-2 via CARD:CARD and DD:DD, respectively. To analyze the PIDDosome assembly,we purified all of the DD superfamily members and performed biochemical analyses. The results revealed that caspase-2CARD is an insoluble protein that can be solubilized by its binding partner, RAIDD CARD, but not by full-length RAIDD;this indicates that full-length RAIDD in closed states cannot interact with caspase-2 CARD. Moreover, we found that caspase-2 CARD can be solubilized and interact with full-length RAIDD in the presence of PIDD DD, indicating that PIDD DD initially binds to RAIDD, after which caspase-2 can be recruited to RAIDD via a CARD:CARD interaction. Our study will be useful in determining the order of assembly of the PIDDosome. [BMB Reports 2013; 46(9): 471-476]
참고문헌 (43)
- Navratil, J. S, "Apoptosis, clearance mechanisms, and the development of systemic lupus erythematosus", Curr. Rheumatol. Rep, 3, pp.191~198 (2001)
- Raff, M. C., "Programmed cell death and the control of cell survival", Philos. Trans. R. Soc. Lond. B. Biol. Sci, 345, pp.265~268 (1994)
- Jacobson, M. D., "Programmed cell death in animal development", Cell, 88, pp.347~354 (1997)
- Park, H. H., "The death domain superfamily in intracellular signaling of apoptosis and inflammation", Annu. Rev. Immunol, 25, pp.561~586 (2007)
- Fisher, D. E., "Pathways of apoptosis and the modulation of cell death in cancer", Hematol. Oncol. Clin. North. Am, 15, pp.931~956 (2001)
- Thompson, C. B., "Apoptosis in the pathogenesis and treatment of disease", Science, 267, pp.1456~1462 (1995)
- Damiano, J. S., "CARD proteins as therapeutic targets in cancer", Curr. Drug. Targets, 5, pp.367~374 (2004)
- de Graaf, A. O., "Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?", Leukemia, 18, pp.1751~1759 (2004)
- Benoist, C., "Cell death mediators in autoimmune diabetes - no shortage of suspects", Cell, 89, pp.1~3 (1997)
- Boatright, K. M., "Mechanisms of caspase activation", Curr. Opin. Cell. Biol, 15, pp.725~731 (2003)
- Pop, C, "Human caspases: Activation, specificity and regulation", J. Biol. Chem, 284, pp.21777~21781 (2009)
- Harvey, N. L, "The role of caspases in apoptosis", Adv. Biochem. Eng. Biotechnol, 62, pp.107~128 (1998)
- Denault, J. B., "Caspases: keys in the ignition of cell death", Chem. Rev, 102, pp.4489~4500 (2002)
- Lavrik, I. N., "Caspases: pharmacological manipulation of cell death", J. Clin. Invest, 115, pp.2665~2672 (2005)
- Salvesen, G. S., "Caspases and apoptosis", Essays Biochem, 38, pp.9~19 (2002)
- Park, H. H., "Structural features of caspase-activating complexes", Int. J. Mol. Sci, 13, pp.4807~4818 (2012)
- Tinel, A., "The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress", Science, 304, pp.843~846 (2004)
- Wajant, H., "The Fas signaling pathway: more than a paradigm", Science, 296, pp.1635~1636 (2002)
- Zou, H., "Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3", Cell, 90, pp.405~413 (1997)
- Martinon, F., "The inflammasomes: guardians of the body", Annu. Rev. Immunol, 27, pp.229~265 (2009)
- Martinon, F., "Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases", Cell, 117, pp.561~574 (2004)
- Park, H. H., "PYRIN domains and their interactions in the apoptosis and inflammation signaling pathway", Apoptosis, 17, pp.1247~1257 (2012)
- Bae, J. Y., "Crystal structure of NALP3 protein pyrin domain (PYD) and its implications in inflammasome assembly", J Biol Chem, 286, pp.39528~39536 (2011)
- Lassus, P., "Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization", Science, 297, pp.1352~1354 (2002)
- Shin, S., "Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8", EMBO J, 24, pp.3532~3542 (2005)
- Park, H. H., "Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex", Cell, 128, pp.533~546 (2007)
- Tinel, A., "Autoproteolysis of PIDD marks the bifurcation between pro-death caspase-2 and pro-survival NF-kappaB pathway", EMBO J, 26, pp.197~208 (2007)
- Duan, H., "RAIDD is a new 'death' adaptor molecule", Nature, 385, pp.86~89 (1997)
- Park, H. H., "Crystal structure of RAIDD death domain implicates potential mechanism of PIDDosome assembly", J. Mol. Biol, 357, pp.358~364 (2006)
- Park, H. H., "Crystallization and preliminary X-ray crystallographic studies of the oligomeric death-domain complex between PIDD and RAIDD", Acta. Crystallogr. Sect. F. Struct. Biol. Cryst. Commun, 63, pp.229~232 (2007)
- Baptiste-Okoh, N., "A role for caspase 2 and PIDD in the process of p53-mediated apoptosis", Proc. Natl. Acad. Sci. U. S. A, 105, pp.1937~1942 (2008)
- Janssens, S., "PIDD mediates NF-kappaB activation in response to DNA damage", Cell, 123, pp.1079~1092 (2005)
- Lin, Y., "Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis", Nat. Genet, 26, pp.122~127 (2000)
- Wu, Z. H., "PIDD: a switch hitter", Cell, 123, pp.980~982 (2005)
- Reed, J. C., "The domains of apoptosis: a genomics perspective", Sci. STKE 2004, re9, ~ (2004)
- Chou, J. J., "Solution structure of the RAIDD CARD and model for CARD", CARD interaction in caspase-2 and caspase-9 recruitment, 1998, pp.94, 171~180
- Park, H. H., "Structural analyses of death domains and their interactions", Apoptosis, 16, pp.209~220 (2011)
- Jang, T. H., "In vitro reconstitution of the interactions in the PIDDosome", Apoptosis, 15, pp.1444~1452 (2010)
- Jang, T. H, "Generalized semi-refolding methods for purification of the functional death domain superfamily", J. Biotechnol, 151, pp.335~342 (2011)
- Eberstadt, M., "NMR structure and mutagenesis of the FADD(Mort1)death-effector domain", Nature, 392, pp.941~945 (1998)
- Scott, F. L., "The Fas-FADD death domain complex structure unravels signalling by receptor clustering", Nature, 457, pp.1019~1022 (2009)
- Eun-Woo Lee, "The roles of FADD in extrinsic apoptosis and necroptosis", BMB Reports, 45(9), pp.496~508 (2012), 생화학분자생물학회
- Jang, T. H., "Identification and analysis of dominant negative mutants of RAIDD and PIDD", Biochim. Biophys. Acta, 1804, pp.1557~1563 (2010)
